Pleiotropic effects of PPAR-α – from benchside to bedside

Por I. V. Shirinsky, V. S. Shirinsky
Publicado em 2021-06-01

Polymorbidity, ageing of immune system and low-grade systemic inflammation: a challenge for modern medicine

Por V. S. Shirinsky, I. V. Shirinsky
Publicado em 2020-08-01

PREDICTION OF CLINICAL EFFICIENCY OF SIMVASTATIN TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS

Por I. V. Shirinsky, V. S. Shirinsky
Publicado em 2014-07-01

EFFECT OF SIMVASTATIN THERAPY UPON IMMUNOLOGICAL MARKERS OF ATHEROSCLEROSIS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS

Por I. V. Shirinsky, V. S. Shirinsky
Publicado em 2014-07-01

EFFECTS OF STATINS UPON ANTIGEN-SPECIFIC LYMPHOCYTE ACTIVATION IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN IN VITRO STUDY

Por I. V. Shirinsky, V. S. Shirinsky
Publicado em 2014-07-01

INFLAMMATION AND IMMUNITY: A ROLE OF PATHOGENESIS OF OSTEOARTHRITIS

Por V. S. Shirinsky, E. V. Kazygasheva, I. V. Shirinsky
Publicado em 2019-01-01

PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY

Por I. V. Shirinsky, N. Yu. Kalinovskaya, V. S. Shirinsky
Publicado em 2019-01-01

DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?

Por E. V. Kazygasheva, V. S. Shirinsky, I. V. Shirinsky
Publicado em 2016-08-01

CULTURES OF FIBROBLAST-LIKE SYNOVIAL CELLS FROM PATIENTS WITH RHEUMATOID ARTHRITIS: PROPERTIES AND OPPORTUNITIES

Por M. A. Schneider, V. S. Shirinsky, I. V. Shirinsky
Publicado em 2016-04-01

CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DIABETES-ASSOCIATED OSTEOARTHRITIS

Por I. V. Shirinsky, N. Yu. Kalinovskaya, V. S. Shirinsky
Publicado em 2015-03-01

IN VITRO EFFECTS OF MEVASTATIN AND BIOLOGICAL PREPARATIONS UPON ACTIVATION OF EBV-SPECIFIC CD4+T LYMPHOCYTES FROM THE PATIENTS WITH RHEUMATOID ARTHRITIS

Por I. V. Shirinsky, V. S. Shirinsky, C. A. Dinarello
Publicado em 2014-07-01

EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS

Por I. V. Shirinsky, V. A. Kozlov, V. S. Shirinsky
Publicado em 2014-07-01

Effect of DNA methylation modulators on the production of osteoprotegerin by rheumatoid fibroblast-like synoviocytes in vitro: their migration and invasion

Por M. A. Shnayder, V. S. Shirinsky, N. Y. Kalinovskaya, I. V. Shirinsky
Publicado em 2019-10-01

Combination treatment of patients with metabolic phenotype of osteoarthritis: an exploratory study

Por V. S. Shirinsky, N. Yu. Kalinovskaya, E. Yu. Filatova, I. V. Shirinsky
Publicado em 2020-12-01

Clinical and immunological features of metabolic phenotype of osteoarthritis

Por V. S. Shirinsky, N. Yu. Kalinovskaya, K. Yu. Filatova, I. V. Shirinsky
Publicado em 2020-04-01

THE PRODUCTION OF PRO- AND ANTIINFLAMMATORY CYTOKINES BY SYNOVIAL FIBROBLASTS OF PATIENTS WITH RHEUMATOID ARTHRITIS IN VITRO WHEN USING DNA METHYLATION MODULATORS - INVESTIGATIVE S...

Por M. A. Shnayder, V. S. Shirinsky, N. Yu. Kalinovskaya, I. V. Shirinsky
Publicado em 2019-05-01

COMORBIDITY, DNA METHYLATION AND AUTOIMMUNITY IN DIABETES-ASSOCIATED OSTEOARTHRITIS: AN EXPLORATORY STUDY

Por I. V. Shirinsky, O. V. Sazonova, N. Yu. Kalinovskaya, V. S. Shirinsky
Publicado em 2015-10-01

CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY

Por I. V. Shirinsky, O. V. Sazonova, N. Yu. Kalinovskaya, V. S. Shirinsky
Publicado em 2016-01-01

CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY

Por V. S. Shirinsky, E. V. Kazygasheva, N. Yu. Kalynovskaya, I. V. Shirinsky
Publicado em 2017-05-01

EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY

Por I. V. Shirinsky, O. I. Zheltova, V. S. Shirinsky, V. A. Kozlov
Publicado em 2014-07-01